Vascular & Endovascular

Normal daily doses of rivaroxaban (15 to 20 mg) are linked to triple the risk of intracerebral hemorrhage (ICH) when compared to aspirin, according to a meta-analysis of five randomized trials published Aug. 13 in JAMA Neurology.
New research published in the European Heart Journal highlights how overall cerebrovascular disease deaths in Europe have declined. But that improvement has leveled off in some EU countries.
Revascularization techniques to treat primary critical limb ischemia (CLI) may be more cost-effective and associated with longer survival than primary major amputation, according to new research published in the Journal of the American Heart Association.
Experimental gene therapies to treat hemophilia are still undergoing testing, but early results from clinical trials have both researchers and patients optimistic the condition can be cured once and for all.
Maintaining an optimal body mass index (BMI), in addition to controlling other cardiovascular risk factors, may reduce the risk of peripheral artery disease (PAD) with critical limb ischemia (CLI), according to new research in the Journal of the American Heart Association.
The factor Xa inhibitor edoxaban might reduce the risk of several adverse events—including stroke, major bleeding and all-cause death—when compared to warfarin, according to a real-world study of Korean patients with atrial fibrillation (AFib).
The FDA has approved migalastat, the first oral medication for the treatment of adults with Fabry disease, the agency announced Aug. 10.
A 45-year-old man who had a stroke now creates “eye-catching” pictures—a talent he didn’t have before the medical emergency. Wayne Sheppard of the United Kingdom now sells some of his paintings for up to $510 (or £400).
The Music Therapy Program at the Texas Health Presbyterian Hospital in Dallas integrates music into stroke patients’ healing process to help patients relax after stroke. It is also a way to help meet health targets set by patients’ speech therapists.
Swedish researchers have identified a potential mechanism for the endothelial dysfunction found in patients with type 2 diabetes (T2D): increased expression of the arginase I protein in red blood cells.
Continued use of statins was associated with a 25 percent reduced risk of major adverse cardiovascular events in patients after carotid revascularization, according to a Canadian study with five years of follow-up. But only about two-thirds of patients were taking moderate to high doses of the drugs prior to their procedures.
Research in the Journal of the Journal of the American Heart Association suggests sleeping beyond the recommended seven to eight hours a night can increase the risk of cardiovascular disease (CVD) and death. 
Researchers from the Cleveland Clinic have developed what could become a new class of cardiovascular drugs—one that lowers platelet responsiveness and excessive clot formation by targeting a specific bacteria byproduct in the gut.
A 13-gene signature can separate Kawasaki disease from other febrile and inflammatory conditions, potentially opening the door to blood tests that allow quicker treatment and the prevention of coronary artery aneurysms.
Atrial fibrillation (AFib) and atrial flutter (AFL) are often regarded as interchangeable when informing the management of stroke risk. However, a new study in JAMA Network Open suggests clinical outcomes are worse for patients with AFib, even if they have the same values on the standard CHA2DS2-VASc scoring system.
Smoking hookah for 30 minutes causes changes in arterial stiffness similar to what’s seen after someone smokes a cigarette, according to a study published in the American Journal of Cardiology.
Vascular & Endovascular, Hypertension
A new North American consensus statement published July 30 in Circulation recommends a non-vitamin K antagonist oral anticoagulant (NOAC) and the P2Y12 inhibitor clopidogrel for most patients with atrial fibrillation undergoing PCI.
Coronary Intervention & Surgery, Electrophysiology & Arrhythmia, Vascular & Endovascular
Researchers with LSU Health New Orleans School of Medicine believe they’ve discovered a molecular explanation for why hypoxia increases the risk for blood clots.
Vascular & Endovascular
Researchers have developed an online tool to more accurately calculate which middle-aged individuals are at the highest risk of heart attack or stroke during the next 10 years.
Acute Coronary Syndrome, Vascular & Endovascular
Rapid Medical has received CE mark approval for its Tigertriever 13 clot retriever, the smallest such device on the market which is designed to treat intracranial vessels between one and 2.5 millimeters.
Vascular & Endovascular
Having a multidisciplinary team available around-the-clock to meet patients with suspected emergent large vessel occlusion (ELVO) strokes helped a hospital achieve median door-to-recanalization times of 52 minutes, according to a study presented at the Society of NeuroInterventional Surgery’s annual meeting.
Vascular & Endovascular, Practice Management, Conferences